TNFSF13 and autoimmune disease: This review will explore the literature on the physiological role of a proliferation-inducing ligand (APRIL) in antibody-producing cells, discuss current insights into APRIL’s role in autoimmune diseases, and consider the potential outcomes of targeting APRIL in comparison to existing B-cell modulating therapies (19–21).